Bryn Mawr’s Noble.MD Gets Million-Dollar Prescription to Launch New Products

Dr. Todd Johnson, CEO of Noble.MD

Area investors are prescribing $1.45 million to help Noble.MD, a health care technology firm in Bryn Mawr, achieve new levels of success. Equity financing from Radnor-based investors Safeguard Scientifics and BioAdvance, along with numerous individual angel investors, will enable Noble.MD to launch two new products and expand its sales and marketing push.

“We have been helping our clients build their patient-reported population health databases for years,” Founder and CEO Dr. Todd Johnson said in a Philadelphia Business Journal report by John George.

“Now we are using that expertise to help our clients directly and immediately enhance their revenue. Patient-reported data is the uncut diamond of health care – it is the key to prospective risk identification.”

Building on the success of its Theo digital health care advisor, Noble.MD’s new products will streamline annual Medicare wellness visits, and hip and knee surgeries.

“We meet with hundreds of entrepreneurial teams who understand innovation but can’t always apply it to health care,” BioAdvance Venture Partner Shahram Hejazi said in the article.

“Noble.MD has a team who understands health care, from integrating invisibly into workflow to increasing revenue to impact on patient health outcomes. These guys get it.”

Click here to read more about the equity funding and Noble.MD’s newest products in the Philadelphia Business Journal.

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.